← All trials

NCT05584670

Phase 1/Phase 2Interventional

Trials that are a combination of phases 1 and 2.

View on ClinicalTrials.gov ↗

Timeline

Start date
Nov 29, 2022
Primary completion
Jun 11, 2027
Completion date
Jun 11, 2027
First posted
Oct 18, 2022
Last posted
Dec 9, 2022
Enrollment
240
Arms / groups
5 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.